Researchers tracked data from more than 2,000 patients, noting that surgical bailout, infective endocarditis and paravalvular leak were the most common reasons for surgery to be required after TAVR. The full study was published in the American Journal of Cardiology.

The company can now update its labeling instructions for the device to include a new 45-day dual anti-platelet therapy treatment option when treating non-valvular atrial fibrillation. 

Juan F. Granada, MD, president and chief executive officer of the Cardiovascular Research Foundation, previewed TCT 2022 for us, detailing what attendees can expect to see at the big show in Boston. 

Atrial secondary mitral regurgitation has been linked to higher in-hospital mortality and hospitalization rates. 

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.

The news comes after the Onyx Frontier DES gained CE mark approval. It received FDA approval in May.

Radiology practices in Arizona and Texas have been hit by hackers.

Julius Bogdan, vice president and general manager of the Healthcare Information and Management Systems Society (HIMSS) Digital Health Advisory Team for North America, explains several key artificial intelligence (AI) trends he sees across healthcare.